Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025)
Anbio Biotechnology has reported Retained Earnings over the past 3 years, most recently at $23.6 million for Q4 2025.
- Quarterly results put Retained Earnings at $23.6 million for Q4 2025, up 37.29% from a year ago — trailing twelve months through Dec 2025 was $23.6 million (up 37.29% YoY), and the annual figure for FY2025 was $23.6 million, up 37.29%.
- Retained Earnings for Q4 2025 was $23.6 million at Anbio Biotechnology, up from $17.2 million in the prior quarter.
- Over the last five years, Retained Earnings for NNNN hit a ceiling of $23.6 million in Q4 2025 and a floor of $14.8 million in Q4 2023.
- Median Retained Earnings over the past 3 years was $17.2 million (2024), compared with a mean of $18.5 million.
- Biggest five-year swings in Retained Earnings: grew 16.03% in 2024 and later soared 37.29% in 2025.
- Anbio Biotechnology's Retained Earnings stood at $14.8 million in 2023, then increased by 16.03% to $17.2 million in 2024, then skyrocketed by 37.29% to $23.6 million in 2025.
- The last three reported values for Retained Earnings were $23.6 million (Q4 2025), $17.2 million (Q4 2024), and $14.8 million (Q4 2023) per Business Quant data.